Nonparametric competing risks analysis using Bayesian Additive Regression Trees (BART)
Rodney Sparapani, Brent R. Logan, Robert E. McCulloch, Purushottam, W. Laud

TL;DR
This paper introduces a flexible Bayesian Additive Regression Trees (BART) approach for analyzing competing risks in time-to-event data, addressing complex relationships and model misspecification issues.
Contribution
It presents a novel BART-based method for competing risks analysis, improving prediction accuracy over traditional models and random survival forests.
Findings
BART outperforms standard regression techniques in simulation studies.
The method effectively captures nonlinearities and interactions.
Application to stem cell transplantation data demonstrates practical utility.
Abstract
Many time-to-event studies are complicated by the presence of competing risks. Such data are often analyzed using Cox models for the cause specific hazard function or Fine-Gray models for the subdistribution hazard. In practice regression relationships in competing risks data with either strategy are often complex and may include nonlinear functions of covariates, interactions, high-dimensional parameter spaces and nonproportional cause specific or subdistribution hazards. Model misspecification can lead to poor predictive performance. To address these issues, we propose a novel approach to flexible prediction modeling of competing risks data using Bayesian Additive Regression Trees (BART). We study the simulation performance in two-sample scenarios as well as a complex regression setting, and benchmark its performance against standard regression techniques as well as random survival…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsStatistical Methods and Inference · Statistical Methods in Clinical Trials · Liver Disease Diagnosis and Treatment
